Literature DB >> 26885188

Targeting SLUG sensitizes leukemia cells to ADR-induced apoptosis.

Chang-Rong Wei1, Jun Liu2, Xiao-Jun Yu3.   

Abstract

BACKGROUND AND AIMS: Slug is an E-cadherin repressor and a suppressor of PUMA (p53 upregulated modulator of apoptosis) and it has recently been demonstrated that Slug plays an important role in controlling apoptosis. In this study, we examined whether Slug's ability to silence expression suppresses the growth of leukemia HL-60 cells and/or sensitizes leukemia HL-60 cells to adriamycin (ADR) through induction of apoptosis.
METHODS: SLUG siRNA was transfected into the HL-60 and HL-60(ADR) cell lines (an adriamycin resistant cell line). The stably SLUG siRNA transfected HL-60 and HL-60(ADR) cells was transiently transfected with PUMA siRNA. The mRNA and protein expression of SLUG and PUMA were determined by Quantitative real-time RT-PCR and Western blot assay. The effects of SLUG siRNA alone or combined with ADR or PUMA siRNA on growth and apoptosis in HL-60 and HL-60(ADR) cells was detected by MTT, ELISA and terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay.
RESULTS: The results showed that SLUG was less expressed in the HL-60 cells, and high expressed in the HL-60(ADR) cells. Obvious down-regulation of SLUG mRNA and protein levels and up-regulation of PUMA mRNA and protein levels after SLUG siRNA transfection was showed in the HL-60(ADR) cells. Treatment with ADR induced SLUG mRNA and protein in the HL-60 cells. Significant positive correlation was observed between basal SLUG mRNA and protein and ADR sensitivity. SLUG gene silencing by SLUG siRNA transfection inhibited growth and induced apoptosis, and increased ADR killing of the HL-60 and HL-60(ADR) cell lines. After the SLUG siRNA transfected HL-60 and HL-60(ADR) cells was transiently transfected with PUMA siRNA, did not increase ADR killing of the HL-60 and HL-60(ADR) cell lines.
CONCLUSION: SLUG level positively correlated with sensitivity to ADR. SLUG siRNA could effectively reduce SLUG expression and induce PUMA expression and restore the drug sensitivity of resistant leukemic cells to conventional chemotherapeutic agents.

Entities:  

Keywords:  Myeloid leukemia; PUMA; SLUG; cytarabine

Year:  2015        PMID: 26885188      PMCID: PMC4729974     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

1.  PUMA induces the rapid apoptosis of colorectal cancer cells.

Authors:  J Yu; L Zhang; P M Hwang; K W Kinzler; B Vogelstein
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

2.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

Review 3.  No PUMA, no death: implications for p53-dependent apoptosis.

Authors:  Jian Yu; Lin Zhang
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

4.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

Review 5.  New strategies in the chemotherapy of leukemia: eradicating cancer stem cells in chronic myeloid leukemia.

Authors:  A Stefanachi; F Leonetti; O Nicolotti; M Catto; L Pisani; S Cellamare; C Altomare; A Carotti
Journal:  Curr Cancer Drug Targets       Date:  2012-06       Impact factor: 3.428

Review 6.  Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.

Authors:  C M Zwaan; G J L Kaspers
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

7.  Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Yasuto Uchikado; Shoji Natsugoe; Hiroshi Okumura; Tetsuro Setoyama; Masataka Matsumoto; Sumiya Ishigami; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

8.  The effect of cantharidins on leukemic stem cells.

Authors:  David C Dorn; Cynthia A Kou; Kim J Png; Malcolm A S Moore
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

9.  The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.

Authors:  Laura M High; Barbara Szymanska; Urszula Wilczynska-Kalak; Nicole Barber; Rosemary O'Brien; Seong Lin Khaw; Ingela B Vikstrom; Andrew W Roberts; Richard B Lock
Journal:  Mol Pharmacol       Date:  2009-12-28       Impact factor: 4.436

Review 10.  Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

Authors:  Michele Baccarani; Jorge Cortes; Fabrizio Pane; Dietger Niederwieser; Giuseppe Saglio; Jane Apperley; Francisco Cervantes; Michael Deininger; Alois Gratwohl; François Guilhot; Andreas Hochhaus; Mary Horowitz; Timothy Hughes; Hagop Kantarjian; Richard Larson; Jerald Radich; Bengt Simonsson; Richard T Silver; John Goldman; Rudiger Hehlmann
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

View more
  4 in total

1.  Targeting of slug sensitizes anaplastic thyroid carcinoma SW1736 cells to doxorubicin via PUMA upregulation.

Authors:  Anbing Dong; Xuelong Jiao; Dong Chen; Fengyun Hao; Kejun Zhang
Journal:  Int J Biochem Mol Biol       Date:  2016-09-30

Review 2.  Emerging roles of epithelial-mesenchymal transition in hematological malignancies.

Authors:  San-Chi Chen; Tsai-Tsen Liao; Muh-Hwa Yang
Journal:  J Biomed Sci       Date:  2018-04-23       Impact factor: 8.410

3.  FtH-Mediated ROS Dysregulation Promotes CXCL12/CXCR4 Axis Activation and EMT-Like Trans-Differentiation in Erythroleukemia K562 Cells.

Authors:  Roberta Chirillo; Ilenia Aversa; Anna Di Vito; Alessandro Salatino; Anna Martina Battaglia; Alessandro Sacco; Maddalena Adriana Di Sanzo; Maria Concetta Faniello; Barbara Quaresima; Camillo Palmieri; Flavia Biamonte; Francesco Costanzo
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

4.  Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway.

Authors:  Zhonghui Zhang; Lei Li; Chen Wu; Guoshu Yin; Pei Zhu; Yalu Zhou; Yuanfan Hong; Hongyu Ni; Zhijian Qian; Wen-Shu Wu
Journal:  Leukemia       Date:  2019-09-06       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.